Evidence map›Paper›PMID 26030104›Full record

ArticleInvestigative ophthalmology & visual science2015

The PEDF Neuroprotective Domain Plus DHA Induces Corneal Nerve Regeneration After Experimental Surgery.

Jiucheng He, M Soledad Cortina, Azucena Kakazu, Haydee E P Bazan

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Lipoxin A 4 (LXA 4 ) for diabetic retinopathy (DR).Indian journal of ophthalmology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Elucidating the structure and functions of Resolvin D6 isomers on nerve regeneration with a distinctive trigeminal transcriptome.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  14. Alternative therapies for dry eye disease.Current opinion in ophthalmology · 2021
    Review
  15. PEDF Gene Deletion Disrupts Corneal Innervation and Ocular Surface Function.Investigative ophthalmology & visual science · 2021
    Article
  16. Review
  17. Article
  18. Review
  19. Plasmacytoid dendritic cells in the eye.Progress in retinal and eye research · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jiucheng HeDepartment of Ophthalmology and Neuroscience Center of Excellence School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States.
M Soledad CortinaDepartment of Ophthalmology, University of Illinois Medical Center, Chicago, Illinois, United States.
Azucena KakazuDepartment of Ophthalmology and Neuroscience Center of Excellence School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States.
Haydee E P BazanDepartment of Ophthalmology and Neuroscience Center of Excellence School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, United States.
Louisiana State University Health Sciences Center New Orleans · USUniversity of Illinois Chicago · US

Funding

Lipid Mediators in Corneal Nerve RegenerationR01EY019465 · NEI · LSU HEALTH SCIENCES CENTER · PI BAZAN, HAYDEE E.P. · 2009 to 2021
$4.0M
NEI NIH HHS R01 EY019465
6 · The paper itself

Abstract

purposeTo compare a 44-mer pigment epithelial-derived factor (PEDF) peptide with neurotrophic activity, and a 34-mer PEDF with antiangiogenic properties in association with docosahexaenoic acid (DHA) in corneal nerve regeneration after experimental surgery.

methodsA corneal stromal dissection was performed in rabbits. Treatment groups received topical 44-mer, 34-mer, or full PEDF plus DHA. Corneal sensitivity and Schirmer's test were performed weekly. Rabbits were euthanized at 2 and 4 days and 8 weeks. Two- and 4-day samples were stained for neutrophils and CD11b+ cells. Corneal nerves were stained with βIII tubulin and calcitonin gene-related peptide (CGRP) antibodies in specimens collected at 8 weeks. Subepithelial nerve plexus density was calculated. A PEDF-receptor (PEDF-R) was analyzed in rabbit corneal epithelial cells (RCEC) by Western blot and immunofluorescence.

resultsInfiltration of CD11b+cells and neutrophils was reduced by treatment with 44-mer PEDF+DHA. A 3-fold increase in subepithelial corneal nerves and CGRP-positive nerves was found in the 44-mer PEDF+DHA-treated group compared with the 34-mer PEDF+DHA- and vehicle-treated groups. There was a 75% recovery of corneal sensitivity by week 7, and Schirmer's test reached control values in the 44-mer PEDF+DHA-treated corneas at 7 weeks. A PEDF-R protein with homology to calcium-independent phospholipase A2ς was expressed in RCEC.

conclusionsThe 44-mer PEDF+DHA, but not the 34-mer PEDF+DHA, promotes functional regeneration of damaged corneal nerves. Forty four-mer PEDF, by activating a corneal epithelial receptor, in conjunction with DHA could be a novel therapeutic agent for the treatment of neurotrophic keratitis and dry eye that develops as a result of corneal nerve damage.

Indexed as

AnimalsCorneaCorneal StromaDisease Models, AnimalDocosahexaenoic AcidsDrug Therapy, CombinationEpithelial CellsEpithelium, CornealEye ProteinsNerve Growth FactorsNerve RegenerationOphthalmic NervePigment Epithelium-Derived FactorRabbitsReceptors, NeuropeptideSerpinsDocosahexaenoic AcidsEye ProteinsNerve Growth FactorsPigment Epithelium-Derived Factorpigment epithelium-derived factor receptorReceptors, NeuropeptideSerpins

Identifiers

PMID26030104
PMCPMC4463800
OpenAlexW1550843531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.